- Home
- STHO vs VTGN Comparison
STHO vs VTGN Comparison
Compare STHO & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STHO
- VTGN
- Stock Information
- Founded
- STHO N/A
- VTGN 1998
- Country
- STHO United States
- VTGN United States
- Employees
- STHO N/A
- VTGN N/A
- Industry
- STHO Real Estate
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- STHO Real Estate
- VTGN Health Care
- Exchange
- STHO Nasdaq
- VTGN Nasdaq
- Market Cap
- STHO 112.7M
- VTGN 130.1M
- IPO Year
- STHO N/A
- VTGN N/A
- Fundamental
- Price
- STHO $7.83
- VTGN $3.95
- Analyst Decision
- STHO
- VTGN
- Analyst Count
- STHO 0
- VTGN 0
- Target Price
- STHO N/A
- VTGN N/A
- AVG Volume (30 Days)
- STHO 40.0K
- VTGN 462.6K
- Earning Date
- STHO 11-07-2025
- VTGN 11-13-2025
- Dividend Yield
- STHO N/A
- VTGN N/A
- EPS Growth
- STHO N/A
- VTGN N/A
- EPS
- STHO N/A
- VTGN N/A
- Revenue
- STHO $117,547,000.00
- VTGN $646,000.00
- Revenue This Year
- STHO N/A
- VTGN $9.14
- Revenue Next Year
- STHO N/A
- VTGN $467.87
- P/E Ratio
- STHO N/A
- VTGN N/A
- Revenue Growth
- STHO N/A
- VTGN N/A
- 52 Week Low
- STHO $6.06
- VTGN $1.90
- 52 Week High
- STHO $12.44
- VTGN $4.65
- Technical
- Relative Strength Index (RSI)
- STHO 55.54
- VTGN 50.16
- Support Level
- STHO $7.08
- VTGN $3.82
- Resistance Level
- STHO $7.62
- VTGN $4.10
- Average True Range (ATR)
- STHO 0.29
- VTGN 0.28
- MACD
- STHO 0.06
- VTGN -0.03
- Stochastic Oscillator
- STHO 67.26
- VTGN 27.61
About STHO Star Holdings Shares of Beneficial Interest
Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties and land and development properties.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.